English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Aim. To study cited in the literature schemes infusion-detoxification therapy and the use of new drugs in addiction. Identify the role of combination therapy in treatment regimens examined. Based on the analysis of the data to evaluate the possibility of incompatibility pharmaceutical drugs and its consequences, it is necessary to ensure the quality and effectiveness of combination therapy introduction of new developments in the medical practice of substance abuse hospitals. Material and methods. The literature on the modernization of infusion-detoxification therapy, the use of new drugs and the proportion of combination therapy in the treatment of substance abuse patients. Profiles of pharmacists, doctors and nurses, and drug toxicology departments of hospitals. 35 questions answered questionnaires 26 pharmacists, 23 physicians (drug treatment, resuscitation) and 51 nurse. Results. It was revealed that the schemes infusion-detoxification upgraded, new drugs are used, which is reflected in the current scientific literature. Significant role in the described combination therapy regimens. Combination therapy does not preclude the pharmaceutical drug incompatibility. Cycles necessary to carry out improvements on the pharmaceutical incompatibility, increasing the availability of information and changing approaches to quality control in combination therapy. Conclusion. Identification of pharmaceutical incompatibility drug regimens of patients is required to ensure the quality of the combined infusiondetoxification and effectiveness of the implementation of new medical developments.

Current sChemes infusion-detoxifiCation in addiCtion. issues its quality assuranCe